ENERGY:
OIL & GAS PRODUCTION
SIC: PHARMACEUTICAL PREPARATIONS
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.
Market Cap | 455.643 Million | Shares Outstanding | 299.765 Million | Avg 30-day Volume | 22.36 Million | ||
P/E Ratio | -2.38717 | Dividend Yield | EPS | -0.708 | |||
Price/Sales | 7.83 | Debt to Equity | -1.53 | EBITDA | -164.3 Million | ||
Price to Book Value | -3.93 | Forward PE | -4.58 | Enterprise Value | 613.061 Million | ||
Total Cash | 79.634 Million | Current Debt | 47.33 Million | Gross Profit | 44.923 Million | ||
BETA | 1.61593 | 52-week High/Low | 2.75 / 0.853 | Price to Cash FLow (P/CF) | -9999999.0 | ||
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 0 | 1 | -100.0% | 0 (0.0%) | 0 (0.0%) | |
Funds Holding: | 157 | 142 | 10.56% | 33 (1.99%) | 30 (1.87%) | 10.0% |
13F shares: | 160.589 Million | 157.547 Million | 1.93% | 42.119 Million | 31.941 Million | 31.86% |
% Ownership | 53.5716 | 57.7493 | -7.23% | 14.0506 | 11.7081 | 20.01% |
New Positions: | 28 | 15 | 86.67% | 8 | 5 | 60.0% |
Increased Positions | 45 | 32 | 40.63% | 11 | 7 | 57.14% |
Closed Positions | 12 | 22 | -45.45% | 5 | 7 | -28.57% |
Reduced Positions | 38 | 48 | -20.83% | 7 | 12 | -41.67% |
Total Calls | 869.569 Thousand | 1.107 Million | -21.44% | 338.9 Thousand | 340.1 Thousand | -0.35% |
Total Puts | 960.691 Thousand | 981.252 Thousand | -2.1% | 112 Thousand | 119.6 Thousand | -6.35% |
PUT/CALL Ratio | 1.1 | 0.89 | 23.6% | 0.33 | 0.35 | -5.71% |
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
MILLIGAN JOHN C.K. IV PRESIDENT/SECRETARY |
|
0 | 2020-11-24 | 2 |
FINIZIO ROBERT G CEO |
|
0 | 2020-11-24 | 4 |
DONEGAN MICHAEL C CHIEF ACCOUNTING OFFICER |
|
0 | 2020-11-24 | 2 |
BORKOWSKI EDWARD EXECUTIVE VICE PRESIDENT |
|
0 | 2020-08-01 | 1 |
WALKER MARLAN D GENERAL COUNSEL |
|
0 | 2020-08-01 | 1 |
|
0 | 2020-06-18 | 2 | |
|
0 | 2020-06-18 | 1 | |
|
0 | 2020-06-18 | 1 | |
|
0 | 2020-06-18 | 1 | |
|
0 | 2020-06-18 | 2 | |
|
0 | 2020-06-18 | 3 | |
|
0 | 2020-06-18 | 2 | |
|
0 | 2020-06-18 | 2 | |
DARECCA JAMES CHIEF FINANCIAL OFFICER |
|
0 | 2020-06-18 | 3 |
KRASSAN MITCHELL CHIEF STRATEGY OFFICER |
|
0 | 2020-03-30 | 1 |
CARTWRIGHT DANIEL A CHIEF FINANCIAL OFFICER |
|
0 | 2020-03-30 | 1 |
|
6,658,371 | 2019-10-25 | 0 | |
|
3,144 | 2019-08-12 | 0 | |
|
0 | 2019-06-20 | 0 | |
|
0 | 2019-06-20 | 0 | |
|
No longer subject to file | 2011-10-04 | 0 | |
|
No longer subject to file | 2011-02-15 | 0 | |
|
No longer subject to file | 2010-12-17 | 0 | |
|
No longer subject to file | 2010-12-17 | 0 | |
|
No longer subject to file | 2010-12-17 | 0 | |
|
0 | 2009-08-14 | 0 | |
KELLEY SKY B PRESIDENT, CEO |
|
3,423,422 | 2009-07-27 | 0 |
|
0 | 2009-07-27 | 0 | |
MANDEL RICHARD H JR |
|
13,100 | 2008-06-21 | 0 |
HAMILTON DAVID S |
|
0 | 2008-06-17 | 0 |
WOODHILL GREGORY PRESIDENT, SECRETARY, CFO |
|
0 | 2008-06-17 | 0 |
CHESTER MICHAEL |
|
0 | 2008-06-17 | 0 |
|
646,000 | 2008-06-17 | 0 | |
JENSEN JULIAN D |
|
0 | 2008-06-17 | 0 |
JENSEN DEVELOPMENT CO FORMER PRESIDENT |
|
0 | 2008-06-17 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
THERAPEUTICS MD INC TXMD | 2021-02-26 22:15:02 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 21:45:03 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 21:15:02 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 20:45:03 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 20:15:03 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 19:45:03 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 19:15:03 UTC | -1.4267 | 1.4967 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 18:45:03 UTC | -1.4345 | 1.5045 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 18:15:02 UTC | -1.4345 | 1.5045 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 17:45:02 UTC | -1.4345 | 1.5045 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 17:15:03 UTC | -1.4345 | 1.5045 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 16:45:03 UTC | -1.4387 | 1.5087 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 16:15:02 UTC | -1.4387 | 1.5087 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 15:45:03 UTC | -1.4387 | 1.5087 | 3800000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 15:15:03 UTC | -1.4387 | 1.5087 | 3900000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 14:45:03 UTC | -2.1383 | 2.2083 | 3900000 |
THERAPEUTICS MD INC TXMD | 2021-02-26 13:00:03 UTC | -2.1383 | 2.2083 | 2200000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments | TXMD | -116678.0 shares, $-142347.16 | 2020-10-31 | N-PORT |
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | TXMD | -900.0 shares, $-1422.0 | 2020-09-30 | N-PORT |
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund | TXMD | -159944.0 shares, $-195131.68 | 2020-10-31 | N-PORT |